전자 처방전 시장 : 세계 산업 규모, 점유율, 동향, 기회 및 예측 - 제품별(솔루션), 서비스별, 전문 분야별, 제공 형태별, 물질별, 지역별, 경쟁별 세분화(2020-2030년)
E-Prescribing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Solutions ), Services, By Specialties, By Delivery Mode, By Substances, By Region and Competition, 2020-2030F
상품코드:1886330
리서치사:TechSci Research
발행일:2025년 12월
페이지 정보:영문 185 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 전자 처방전 시장은 2024년에 29억 4,000만 달러로 평가되며, 2030년까지 CAGR 8.39%로 성장하며, 47억 7,000만 달러에 달할 것으로 예측됩니다. 전자처방전이란 의료 처방전을 전자적으로 작성, 전송 및 이동하는 것을 의미하며, 기존의 종이 기반 방식을 대체하여 효율성과 환자 안전성을 향상시킵니다. 시장 확대는 근본적으로 통합 전자 건강 기록 솔루션의 도입 확대, 디지털 건강 증진을 위한 정부 정책, 약물 오남용을 줄이고 규제 약물 남용을 방지해야 하는 시급한 필요성에 의해 주도되고 있습니다.
시장 개요
예측 기간
2026-2030
시장 규모 : 2024년
29억 4,000만 달러
시장 규모 : 2030년
47억 7,000만 달러
CAGR : 2025-2030년
8.39%
가장 빠르게 성장하는 부문
솔루션
최대 시장
북미
주요 시장 성장 촉진요인
통합 전자건강기록(EHR) 시스템 도입 확대는 처방 워크플로우를 위한 디지털 기반을 구축함으로써 전 세계 전자처방전 시장을 근본적으로 견인하고 있습니다. 전자처방전이 종합적인 EHR 플랫폼에 통합되면 의료진은 환자의 병력, 알레르기 정보, 복약리스트에 접근할 수 있으며, 보다 안전한 처방전 발급이 가능해집니다.
주요 시장 과제
세계 전자처방전 시장 확대를 가로막는 가장 큰 문제는 상호운용성 문제가 여전히 존재한다는 점입니다. 서로 다른 전자 건강 기록 시스템과 약국 시스템은 종종 원활한 통신 기능이 부족하여 환자 데이터가 파편화되어 상당한 비효율을 초래합니다.
주요 시장 동향
시장에서는 기존의 규칙 기반 경보를 넘어 첨단 인공지능(AI)과 머신러닝 기능을 통합한 AI 탑재 임상의사결정지원시스템의 통합이 두드러진 추세로 관찰되고 있습니다. 이 첨단 시스템은 종합적인 병력, 유전체 정보, 실시간 생체 측정 데이터를 포함한 방대한 환자 데이터를 분석하여 고도로 개인화된 치료 권장 사항을 생성하도록 설계되었습니다.
목차
제1장 개요
제2장 조사 방법
제3장 개요
제4장 고객의 소리
제5장 세계의 전자 처방전 시장 전망
시장 규모·예측
금액별
시장 점유율·예측
제품별(솔루션, 서비스)
전문 분야별(종양학, 스포츠 의학, 신경학, 심장병학, 기타)
제공 형태별(웹/클라우드 기반, 온프레미스)
물질별(규제 물질, 비규제 물질)
지역별
기업별(2024)
시장 맵
제6장 북미의 전자 처방전 시장 전망
시장 규모·예측
시장 점유율·예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 전자 처방전 시장 전망
시장 규모·예측
시장 점유율·예측
유럽 : 국가별 분석
독일
프랑스
영국
이탈리아
스페인
제8장 아시아태평양의 전자 처방전 시장 전망
시장 규모·예측
시장 점유율·예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 중동 및 아프리카의 전자 처방전 시장 전망
시장 규모·예측
시장 점유율·예측
중동 및 아프리카 : 국가별 분석
사우디아라비아
아랍에미리트
남아프리카공화국
제10장 남미의 전자 처방전 시장 전망
시장 규모·예측
시장 점유율·예측
남미 : 국가별 분석
브라질
콜롬비아
아르헨티나
제11장 시장 역학
촉진요인
과제
제12장 시장 동향과 발전
합병·인수
제품 출시
최근 동향
제13장 세계의 전자 처방전 시장 : SWOT 분석
제14장 Porter's Five Forces 분석
업계내 경쟁
신규 참여의 가능성
공급업체의 힘
고객의 힘
대체품의 위협
제15장 경쟁 구도
Oracle Corporation
Veradigm LLC
Epic Systems Corporation
Athenahealth, Inc.
NextGen Healthcare, Inc.
McKesson Corporation
Surescripts, LLC
Change Healthcare LLC
Practice Fusion, Inc.
Networking Technology, Inc.
제16장 전략적 제안
제17장 조사회사 소개·면책사항
KSA
영문 목차
영문목차
The Global E-Prescribing Market, valued at USD 2.94 Billion in 2024, is projected to experience a CAGR of 8.39% to reach USD 4.77 Billion by 2030. E-prescribing refers to the electronic generation, transmission, and fulfillment of medical prescriptions, replacing traditional paper-based methods to enhance efficiency and patient safety. The market's expansion is fundamentally driven by the increasing adoption of integrated electronic health record solutions, governmental initiatives promoting digital health, and a critical need to mitigate medication errors and combat controlled substance abuse.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 2.94 Billion
Market Size 2030
USD 4.77 Billion
CAGR 2025-2030
8.39%
Fastest Growing Segment
Solutions
Largest Market
North America
Key Market Drivers
The increasing adoption of integrated Electronic Health Record (EHR) systems fundamentally drives the global e-prescribing market by establishing a digital infrastructure for prescription workflows. When e-prescribing is embedded within comprehensive EHR platforms, healthcare providers access patient histories, allergy information, and medication lists, enabling informed and safer prescribing. This integration boosts clinical efficiency and care coordination, streamlining the entire medication management process.
Key Market Challenges
A significant challenge impeding the global e-prescribing market expansion is the persistent issue of interoperability. Disparate electronic health record and pharmacy systems frequently lack seamless communication capabilities, resulting in fragmented patient data and substantial inefficiencies. This fragmentation creates data silos, preventing comprehensive patient information exchange necessary for accurate and safe medication management across the healthcare continuum.
Key Market Trends
The market is observing a significant trend in the integration of AI-powered clinical decision support systems, moving beyond conventional rule-based alerts to embed sophisticated artificial intelligence and machine learning capabilities. These advanced systems are engineered to analyze extensive patient data, including comprehensive medical histories, genomic information, and real-time biometric inputs, to generate highly personalized treatment recommendations. This enables prescribers to anticipate potential drug interactions with enhanced accuracy, identify subtle disease progression patterns, and tailor medication regimens precisely to individual patient needs. The integration of such intelligent tools signifies a fundamental shift towards a more proactive and data-driven approach to patient care, where decision support is not merely reactive but predictive.
Key Market Players
Oracle Corporation
Veradigm LLC
Epic Systems Corporation
Athenahealth, Inc.
NextGen Healthcare, Inc.
McKesson Corporation
Surescripts, LLC
Change Healthcare LLC
Practice Fusion, Inc.
Networking Technology, Inc.
Report Scope:
In this report, the Global E-Prescribing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
E-Prescribing Market, By Product:
Solutions
Services
E-Prescribing Market, By Specialties:
Oncology
Sports Medicine
Neurology
Cardiology
Others
E-Prescribing Market, By Delivery Mode:
Web/Cloud Based
On Premise
E-Prescribing Market, By Substances:
Controlled Substances
Non-controlled Substances
E-Prescribing Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global E-Prescribing Market.
Available Customizations:
Global E-Prescribing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global E-Prescribing Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Solutions, Services)
5.2.2. By Specialties (Oncology, Sports Medicine, Neurology, Cardiology, Others)
5.2.3. By Delivery Mode (Web/Cloud Based, On Premise)
5.2.4. By Substances (Controlled Substances, Non-controlled Substances)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Market Map
6. North America E-Prescribing Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Specialties
6.2.3. By Delivery Mode
6.2.4. By Substances
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States E-Prescribing Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Specialties
6.3.1.2.3. By Delivery Mode
6.3.1.2.4. By Substances
6.3.2. Canada E-Prescribing Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Specialties
6.3.2.2.3. By Delivery Mode
6.3.2.2.4. By Substances
6.3.3. Mexico E-Prescribing Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Specialties
6.3.3.2.3. By Delivery Mode
6.3.3.2.4. By Substances
7. Europe E-Prescribing Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Specialties
7.2.3. By Delivery Mode
7.2.4. By Substances
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany E-Prescribing Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Specialties
7.3.1.2.3. By Delivery Mode
7.3.1.2.4. By Substances
7.3.2. France E-Prescribing Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Specialties
7.3.2.2.3. By Delivery Mode
7.3.2.2.4. By Substances
7.3.3. United Kingdom E-Prescribing Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Specialties
7.3.3.2.3. By Delivery Mode
7.3.3.2.4. By Substances
7.3.4. Italy E-Prescribing Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Specialties
7.3.4.2.3. By Delivery Mode
7.3.4.2.4. By Substances
7.3.5. Spain E-Prescribing Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Specialties
7.3.5.2.3. By Delivery Mode
7.3.5.2.4. By Substances
8. Asia Pacific E-Prescribing Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Specialties
8.2.3. By Delivery Mode
8.2.4. By Substances
8.2.5. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China E-Prescribing Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Specialties
8.3.1.2.3. By Delivery Mode
8.3.1.2.4. By Substances
8.3.2. India E-Prescribing Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Specialties
8.3.2.2.3. By Delivery Mode
8.3.2.2.4. By Substances
8.3.3. Japan E-Prescribing Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Specialties
8.3.3.2.3. By Delivery Mode
8.3.3.2.4. By Substances
8.3.4. South Korea E-Prescribing Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Specialties
8.3.4.2.3. By Delivery Mode
8.3.4.2.4. By Substances
8.3.5. Australia E-Prescribing Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Specialties
8.3.5.2.3. By Delivery Mode
8.3.5.2.4. By Substances
9. Middle East & Africa E-Prescribing Market Outlook
